RE:RE:RE:Decent News TodayI think you are referring to testing for different viruses and pathogens. This is "updated" research to be shared with government and others, so with Covid still front and centre, I cannot envision them distracting potential clients by tackling areas of lesser concern. In any case, we will one day see what this is, but at that time we may not care as much since we will likely have the HC word on it. I think the one thing they are not properly explaining is the idea of not needing HC and FDA approvals. I think what they are trying to say is that they do not need their approvals to sell the product as is. But you can bet your bottom dollar that some kind of a positive confirmation about the claims will help, regardless of whether that constitutes an "approval" or not, in people's minds. In any case, regardless of what happened today and the share price, this play is just at the front end of its journey. I wouldn't wanna be a trader trying to chase nickels and dimes.
wilander wrote: Paul has been clear this technology can be more than just Biocloud. And dont forget they set up their scientific advisory committee to look at expanding capability to other uses. We are still in the early innings as I see it.